TRASYLOL, or its generic name aprotinin, was manufactured by Bayer AG. It was designed to prevent internal bleeding during surgeries. Specifically, Trasylol was designed to slow down the bodies' natural process of breaking down blood clots -- it was designed to prevent excessive bleeding during surgery.
After being introduced in the market, studies were conducted regarding Trasylol. These studies produced some very alarming findings regarding the side effects and complications caused by TRASYLOL.
One of these studies, performed at Duke University from 1996 - 2005 and reported in The New England Journal of Medicine, determined that patients who were given TRASYLOL during heart-bypass surgery were subjected to: twice the risk of renal (kidney) failure, 55% increase in heart failure, and 181% increase in the risk of suffering a stroke. Most alarming, when those who received Trayslol were compared to the patients who were given other similar drugs, it was determiend that those patients given Trasylol had nearly 2.5 times greater death rates.
In response to the Duke study, Bayer conducted a 3 year study in which 78,000 people given TRASYLOL during surgery were observed. In this study, Bayer compared those given Trasylol to patients given other similar drugs. After studying the information, Bayer's study concluded that those given Trasylol had a 64% higher risk of dying compared to those given other drugs.
Bayer aggresively marketed the drug since it was put on the market in 1993. In fact, TRASYLOL is estimated to have been used in 1/3 of all cardiac by-pass operations in the U.S. Because Bayer marketed the drug so aggresively, many lives have been effected. In fact, as reported by C.B.S. on its show 60 Minutes, 22,000 people have died as a result of being given Trayslol during surgery.
Based on the alarming evidence and the F.D.A.'s request to pull the drug from the U.S. market due to the safety concers, TRASYLOL was removed from the world market by Bayer AG in November of 2007.
You may have been given Trasylol during surgery if you or a loved one have sufferred from any of the following conditions following surgery:
-
Heart Attack
-
Congestive Heart Failure
-
Stroke
-
Kidney Failure
-
Encepholopathy
-
Blood Clotting
-
Death
If you have suffered from any of the above conditions or events following surgery, contact Todd & Todd, PLLC. We'll discuss the issues you are facing and work to ensure your rights as a consumer are protected.
___________________________________________________________
FOR ARTICLES AND INFORMATION RELATED TO TRASYLOL AND ITS RISKS, PLEASE REVIEW THE LINKS BELOW.
The New England Journal of Medicine:
Food & Drug Administration:
News:
